Minerva Biotechnologies is the older company (1999 vs 2010).
Side-by-Side Comparison
| Metric | Minerva Biotechnologies | Oncoinvent ASA |
|---|---|---|
| Founded | ||
| Founded | 1999 older | 2010 |
| Headquarters | ||
| Headquarters | Waltham, United States | Oslo, Norway |
| Employees | ||
| Employees | 17 | 47 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Unknown | Series Unknown |
| Total Funding | ||
| Total Funding | $61.30M | $281.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 3 |
| Services | ||
| Services | Development of cancer immunotherapies, Research and development in regenerative medicine, iPSC (induced pluripotent stem cell) technology, Clinical trial implementation, Patient-derived stem cell techniques | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech researchers, Healthcare institutions, Oncology specialists, Regenerative medicine professionals | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Immunotherapies, Solid Tumor Cancers, Cellular Therapies, Regenerative Medicine, Clinical Stage, CAR-T Cell Therapy, Metastatic Breast Cancer, MUC1* Growth Factor Receptor, Cancer Metastasis, Stem Cell Technology, Human Naïve State Pluripotent Stem Cells, Cancer Immunotherapy, Transplant Medicine, Pluripotent Stem Cells | Oncoinvent, Radiopharmaceuticals, Radspherin, Alpha-emitting Radionuclides, Cancer Treatment, Clinical Stage Company, Metastatic Cancers, Radiotherapeutic Products, Radioimmunotherapeutic Products, Solid Cancers, Clinical Trials, Oslo, Laboratory Facilities, CGMP |
| Website | ||
| Website | minervabio.com | oncoinvent.com |
About Minerva Biotechnologies
Minerva Biotechnologies, founded in 1999 and headquartered in the United States, is a clinical stage biopharmaceutical company noted for its tagline: "We see the future first." The company focuses on developing groundbreaking immunotherapies for solid tumor cancers and advanced cellular therapies fo...
About Oncoinvent ASA
Oncoinvent AS is a biotechnology startup based in Norway that was founded in 2010. The company's slogan, "Innovations for better cancer care," encapsulates its mission to develop new and innovative radiopharmaceutical products for improved treatment options for cancer patients. Its lead product cand...
We will tell you when either one moves
BounceWatch watches Minerva Biotechnologies and Oncoinvent ASA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Minerva Biotechnologie... and Oncoinvent ASA — by email.
Frequently Asked Questions
Compare Minerva Biotechnologies with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Minerva Biotechnologies on 11 Mar 2026, and Oncoinvent ASA on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
